Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 36

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

257

WORD

HTML

2029

Tables (1-3)

232

Sum=2602

Publishing Process of This Article

Item

Count

Browse

227

Download

570

Sum=797

Dec 26, 2021 (publication date) through Dec 31, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Dec 26, 2021; 9(36): 11248-11254
Published online Dec 26, 2021. doi: 10.12998/wjcc.v9.i36.11248

Table 3 Comparison of adverse cardiovascular events between the two groups at 1 mo after operation, n (%)

Group	n	Malignant arrhythmia	Intractable myocardial ischemia	Congestive heart failure	Recurrent myocardial infarction	Death	Overall incidence
Experimental	360	3	3	4	5	1	16 (4.4)
Control	380	8	5	7	14	2	36 (9.5)
χ²value							9.124
P value							0.001

Citation: Yu Y, Yang BP. Sodium nitroprusside injection immediately before balloon inflation during percutaneous coronary intervention. World J Clin Cases 2021; 9(36): 11248-11254
URL: https://www.wjgnet.com/2307-8960/full/v9/i36/11248.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i36.11248